Taiwo B - Search Results

1

Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. Ghosn J, et al. Among authors: taiwo b. Lancet. 2018 Aug 25;392(10148):685-697. doi: 10.1016/S0140-6736(18)31311-4. Epub 2018 Jul 23. Lancet. 2018. PMID: 30049419 Review.

2

Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings.

Taiwo BO, Murphy R. Taiwo BO, et al. J Int Assoc Physicians AIDS Care (Chic). 2007 Sep;6(3):188-97. doi: 10.1177/1545109707300683. Epub 2007 May 1. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17473177

3

Understanding transmitted HIV resistance through the experience in the USA.

Taiwo B. Taiwo B. Int J Infect Dis. 2009 Sep;13(5):552-9. doi: 10.1016/j.ijid.2008.10.008. Epub 2009 Jan 10. Int J Infect Dis. 2009. PMID: 19136289 Free article. Review.

4

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

Taiwo B, Hicks C, Eron J. Taiwo B, et al. J Antimicrob Chemother. 2010 Jun;65(6):1100-7. doi: 10.1093/jac/dkq096. Epub 2010 Mar 25. J Antimicrob Chemother. 2010. PMID: 20348088 Review.

5

Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting.

Taiwo BO, Idoko JA, Welty LJ, Otoh I, Job G, Iyaji PG, Agbaji O, Agaba PA, Murphy RL. Taiwo BO, et al. J Acquir Immune Defic Syndr. 2010 May 1;54(1):85-92. doi: 10.1097/01.qai.0000371678.25873.1c. J Acquir Immune Defic Syndr. 2010. PMID: 20418724 Clinical Trial.

6

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C. Taiwo B, et al. Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Drugs. 2010. PMID: 20731472 Review.

7

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.

Taiwo B, Gallien S, Aga E, Ribaudo H, Haubrich R, Kuritzkes DR, Eron JJ Jr. Taiwo B, et al. J Infect Dis. 2011 Aug 15;204(4):515-20. doi: 10.1093/infdis/jir353. J Infect Dis. 2011. PMID: 21791652 Free PMC article.

8

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

Taiwo B, Zheng L, Gallien S, Matining RM, Kuritzkes DR, Wilson CC, Berzins BI, Acosta EP, Bastow B, Kim PS, Eron JJ Jr; ACTG A5262 Team. Taiwo B, et al. AIDS. 2011 Nov 13;25(17):2113-22. doi: 10.1097/QAD.0b013e32834bbaa9. AIDS. 2011. PMID: 21857490 Free PMC article. Clinical Trial.

9

Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.

Maiga AI, Fofana DB, Maiga AC, Diallo F, Ait-Arkoub Z, Daou F, Cisse M, Sarro YD, Oumar AA, Sylla A, Katlama C, Taiwo B, Murphy R, Tounkara A, Marcelin AG, Calvez V. Maiga AI, et al. Among authors: taiwo b. AIDS Res Hum Retroviruses. 2013 Jan;29(1):182-6. doi: 10.1089/AID.2012.0118. Epub 2012 Aug 27. AIDS Res Hum Retroviruses. 2013. PMID: 22823755 Free PMC article.

10

Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting.

Maiga AI, Fofana DB, Cisse M, Diallo F, Maiga MY, Traore HA, Maiga IA, Sylla A, Fofana D, Taiwo B, Murphy R, Katlama C, Tounkara A, Calvez V, Marcelin AG. Maiga AI, et al. Among authors: taiwo b. J Antimicrob Chemother. 2012 Dec;67(12):2943-8. doi: 10.1093/jac/dks310. Epub 2012 Aug 10. J Antimicrob Chemother. 2012. PMID: 22888273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page